Polypid Ltd (PYPD)

08:24 AM

What drives PolyPid Ltd. stock priceConsistent high-yield stocks - Autocar Professional

08:24 AM

08:11 AM

What analysts say about PolyPid Ltd. stockUnmatched profit growth - jammulinksnews.com

08:11 AM

Jul 22, 2025

PolyPid Ltd. Stock Analysis and ForecastSuperior stock growth - jammulinksnews.com

Jul 22, 2025

Jul 20, 2025

Is PolyPid Ltd. a good long term investmentFree High-Return Strategy Alerts - jammulinksnews.com

Jul 20, 2025

Jul 16, 2025

PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market - The Globe and Mail

Jul 16, 2025

Jul 16, 2025

PYPD: Positive Topline Data From D-PLEX₁₀₀ Trial Contributes to Multiple Subsequent Benefits - Yahoo Finance

Jul 16, 2025

Jul 15, 2025

PolyPid's Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market - openPR.com

Jul 15, 2025

Jul 15, 2025

How PolyPid Ltd. stock performs during market volatilityFree Exclusive Stock Market Insights - Newser

Jul 15, 2025

Jul 15, 2025

What makes PolyPid Ltd. stock price move sharplyFree Exclusive Stock Market Insights - Newser

Jul 15, 2025

Jul 15, 2025

Analysts Set PolyPid Ltd. (NASDAQ:PYPD) Price Target at $11.80 - Defense World

Jul 15, 2025

Jul 15, 2025

Finance Herald Publishes Coverage of PolyPid's Groundbreaking New 60-Day GLP-1 Delivery Tech - The Manila Times

Jul 15, 2025

Jul 15, 2025

PolyPid unveils 60-day GLP-1 delivery platform for diabetes treatment - Investing.com Australia

Jul 15, 2025

Jul 15, 2025

PolyPid Unveils a Long-Acting GLP-1 Receptor Agonists - GlobeNewswire

Jul 15, 2025

Jul 15, 2025

Revolutionary 60-Day GLP-1 Injection Could Replace Weekly Diabetes Treatments, PolyPid Announces - Stock Titan

Jul 15, 2025

Jul 15, 2025

Why PolyPid Ltd. stock attracts strong analyst attentionReliable Low Risk Signals - Newser

Jul 15, 2025

Jul 12, 2025

PolyPid (NASDAQ:PYPD) Raised to “Hold” at Wall Street Zen - Defense World

Jul 12, 2025

Jul 09, 2025

PolyPid (NASDAQ:PYPD) Stock Price Down 0.6% – Here’s What Happened - Defense World

Jul 09, 2025

Jul 06, 2025

Is PolyPid Stock Undervalued? (NASDAQ: PYPD) - newsblaze.com

Jul 06, 2025

Jul 03, 2025

PolyPid Announces $26.7 Million Warrant Inducement Transaction - Global Legal Chronicle

Jul 03, 2025

Jun 25, 2025

PolyPid Approves Key Resolutions at Annual Shareholder Meeting - TipRanks

Jun 25, 2025

Jun 20, 2025

Brokerages Set PolyPid Ltd. (NASDAQ:PYPD) PT at $11.25 - Defense World

Jun 20, 2025

Jun 19, 2025

PolyPid (NASDAQ:PYPD) Given a $9.00 Price Target by Roth Capital Analysts - Defense World

Jun 19, 2025

Jun 18, 2025

Roth Capital Adjusts Price Target on PolyPid to $9 From $12, Maintains Buy Rating - MarketScreener

Jun 18, 2025

Jun 18, 2025

Roth Capital Adjusts PolyPid (PYPD) Price Target Amid New Financing | PYPD Stock News - GuruFocus

Jun 18, 2025

Jun 18, 2025

PolyPid (NASDAQ:PYPD) Given New $14.00 Price Target at JMP Securities - Defense World

Jun 18, 2025

Jun 17, 2025

PYPD: JMP Securities Lowers Price Target While Maintaining Marke - GuruFocus

Jun 17, 2025

Jun 17, 2025

PolyPid (PYPD) Price Target Adjusted Amid Financing Developments - GuruFocus

Jun 17, 2025

Jun 17, 2025

PolyPid stock price target lowered to $14 at JMP on warrant dilution By Investing.com - Investing.com South Africa

Jun 17, 2025

Jun 17, 2025

PolyPid stock price target lowered to $14 at JMP on warrant dilution - Investing.com Australia

Jun 17, 2025

Jun 17, 2025

PolyPid Secures $26.7 Million Post-Successful Phase 3 Trial - TipRanks

Jun 17, 2025

Jun 17, 2025

Citizens JMP Adjusts Price Target for PolyPid (PYPD) Amid Warrant Developments | PYPD Stock News - GuruFocus

Jun 17, 2025

Jun 16, 2025

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results - GlobeNewswire

Jun 16, 2025

Jun 16, 2025

PolyPid Secures $26.7M Funding Following Breakthrough Phase 3 Results in Surgical Infection Prevention - Stock Titan

Jun 16, 2025

Jun 13, 2025

FY2026 Earnings Forecast for PolyPid Issued By HC Wainwright - Defense World

Jun 13, 2025